|
1
|
Lu K and Wang X: Therapeutic advancement
of chronic lymphocytic leukemia. J Hematol Oncol. 5:552012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bilous N, Abramenko I, Saenko V, Chumak A,
Dyagil I, Martina Z and Kryachok I: Clinical relevance of TP53
polymorphic genetic variations in chronic lymphocytic leukemia.
Leuk Res. 58:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nasr R, Marçais A, Hermine O and
Bazarbachi A: Overview of targeted therapies for adult T-cell
leukemia/lymphoma. Methods Mol Biol. 1582:197–216. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jin UH, Cheng Y, Zhou B and Safe S:
Bardoxolone methyl and a related triterpenoid downregulate cMyc
expression in leukemia cells. Mol Pharmacol. 91:438–450. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Quintanilla-Martinez L, Preffer F, Rubin
D, Ferry JA and Harris NL: CD20+ T-cell lymphoma: Neoplastic
transformation of a normal T-cell subset. Am J Clin Pathol.
102:483–489. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moens L, Verbinnen B, Covens K, Wuyts G,
Johnson M, Roalfe L, Goldblatt D, Meyts I and Bossuyt X:
Anti-pneumococcal capsular polysaccharide antibody response and CD5
B lymphocyte subsets. Infect Immun. 83:2889–2896. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Balatti V, Tomasello L, Rassenti LZ,
Veneziano D, Nigita G, Wang HY, Thorson JA, Kipps TJ, Pekarsky Y
and Croce CM: miR-125a and miR-34a expression predicts Richter
syndrome in chronic lymphocytic leukemia patients. Blood.
132:2179–2182. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Papageorgiou SG, Kontos CK, Diamantopoulos
MA, Bouchla A, Glezou E, Bazani E, Pappa V and Scorilas A:
MicroRNA-155-5p overexpression in peripheral blood mononuclear
cells of chronic lymphocytic leukemia patients is a novel,
independent molecular biomarker of poor prognosis. Dis Markers.
2017:20465452017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zitzer NC, Snyder K, Meng X, Taylor PA,
Efebera YA, Devine SM, Blazar BR, Garzon R and Ranganathan P:
MicroRNA-155 modulates acute graft-versus-host disease by impacting
T cell expansion, migration, and effector function. J Immunol.
200:4170–4179. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou B, Zhu H, Luo H, Gao S, Dai X, Li Y
and Zuo X: MicroRNA-202-3p regulates scleroderma fibrosis by
targeting matrix metalloproteinase 1. Biomed Pharmacother.
87:412–418. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oscier D, Else M, Matutes E, Morilla R,
Strefford JC and Catovsky D: The morphology of CLL revisited: The
clinical significance of prolymphocytes and correlations with
prognostic/molecular markers in the LRF CLL4 trial. Br J Haematol.
174:767–775. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kriston C, Bödör C, Szenthe K, Bánáti F,
Bánkuti B, Csernus B, Reiniger L, Csomor J, Matolcsy A and Barna G:
Low CD23 expression correlates with high CD38 expression and the
presence of trisomy 12 in CLL. Hematol Oncol. 35:58–63. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Underbayev C, Kasar S, Ruezinsky W,
Degheidy H, Schneider JS, Marti G, Bauer SR, Fraidenraich D,
Lightfoote MM, Parashar V, et al: Role of mir-15a/16-1 in early B
cell development in a mouse model of chronic lymphocytic leukemia.
Oncotarget. 7:60986–60999. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dong C, Ji M and Ji C: microRNAs and their
potential target genes in leukemia pathogenesis. Cancer Biol Ther.
8:200–205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Smolej L, Vroblova V, Motyckova M,
Jankovicova K, Schmitzova D, Krejsek J and Maly J: Quantification
of ZAP-70 expression in chronic lymphocytic leukemia: T/B-cell
ratio of mean fluorescence intensity provides stronger prognostic
value than percentage of positive cells. Neoplasma. 58:140–145.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ferrajoli A, Shanafelt TD, Ivan C, Shimizu
M, Rabe KG, Nouraee N, Ikuo M, Ghosh AK, Lerner S, Rassenti LZ, et
al: Prognostic value of miR-155 in individuals with monoclonal
B-cell lymphocytosis and patients with B chronic lymphocytic
leukemia. Blood. 122:1891–1899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan C, Chen Y, Kong W, Fu L, Liu Y, Yao Q
and Yuan Y: PVT1-derived miR-1207-5p promotes breast cancer cell
growth by targeting STAT6. Cancer Sci. 108:868–876. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen N, Lu K, Li P, Lv X and Wang X:
Overexpression of IL-9 induced by STAT6 activation promotes the
pathogenesis of chronic lymphocytic leukemia. Int J Clin Exp
Pathol. 7:2319–2323. 2014.PubMed/NCBI
|
|
19
|
Chen N, Lv X, Li P, Lu K and Wang X: Role
of high expression of IL-9 in prognosis of CLL. Int J Clin Exp
Pathol. 7:716–721. 2014.PubMed/NCBI
|
|
20
|
Kneitz C, Goller M, Seggewiss R, Yaman A,
Serfling E and Tony HP: STAT6 and the regulation of CD23 expression
in B-chronic lymphocytic leukemia. Leuk Res. 24:331–337. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jeon JI, Ko SH, Kim YJ, Choi SM, Kang KK,
Kim H, Yoon HJ and Kim JM: The flavone eupatilin inhibits eotaxin
expression in an NF-κB-dependent and STAT6-independent manner.
Scand J Immunol. 81:166–176. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eigsti RL, Sudan B, Wilson ME and Graff
JW: Regulation of activation-associated microRNA accumulation rates
during monocyte-to-macrophage differentiation. J Biol Chem.
289:28433–28447. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rückerl D, Jenkins SJ, Laqtom NN,
Gallagher IJ, Sutherland TE, Duncan S, Buck AH and Allen JE:
Induction of IL-4Rα-dependent microRNAs identifies PI3K/Akt
signaling as essential for IL-4-driven murine macrophage
proliferation in vivo. Blood. 120:2307–2316. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gautherot I, Burdin N, Seguin D, Aujame L
and Sodoyer R: Cloning of interleukin-4 delta2 splice variant
(IL-4delta2) in chimpanzee and cynomolgus macaque: phylogenetic
analysis of delta2 splice variant appearance, and implications for
the study of IL-4-driven immune processes. Immunogenetics.
54:635–644. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei Y and Schober A: MicroRNA regulation
of macrophages in human pathologies. Cell Mol Life Sci.
73:3473–3495. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Czimmerer Z, Varga T, Kiss M, Vázquez CO,
Doan-Xuan QM, Rückerl D, Tattikota SG, Yan X, Nagy ZS, Daniel B, et
al: The IL-4/STAT6 signaling axis establishes a conserved microRNA
signature in human and mouse macrophages regulating cell survival
via miR-342-3p. Genome Med. 8:632016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ying W, Tseng A, Chang RC, Morin A, Brehm
T, Triff K, Nair V, Zhuang G, Song H, Kanameni S, et al:
MicroRNA-223 is a crucial mediator of PPARγ-regulated alternative
macrophage activation. J Clin Invest. 125:4149–4159. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Friedländer MR, Lizano E, Houben AJ,
Bezdan D, Báñez-Coronel M, Kudla G, Mateu-Huertas E, Kagerbauer B,
González J, Chen KC, et al: Evidence for the biogenesis of more
than 1,000 novel human microRNAs. Genome Biol. 15:R572014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Srivastava AK, Sablok G, Hackenberg M,
Deshpande U and Suprasanna P: Thiourea priming enhances salt
tolerance through co-ordinated regulation of microRNAs and hormones
in Brassica juncea. Sci Rep. 7:454902017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pallasch CP, Patz M, Park YJ, Hagist S,
Eggle D, Claus R, Debey-Pascher S, Schulz A, Frenzel LP, Claasen J,
et al: miRNA deregulation by epigenetic silencing disrupts
suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.
Blood. 114:3255–3264. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Abroun S, Saki N, Ahmadvand M, Asghari F,
Salari F and Rahim F: STATs: An old story, yet mesmerizing. Cell J.
17:395–411. 2015.PubMed/NCBI
|
